Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SpringRock Ventures is a Seattle-based venture capital firm focused on the intersection of healthcare and information technology. The firm invests in high growth-potential companies across various stages, with a fund size that allows for investments between $2 million and $5 million. They primarily operate in North America and have a keen interest in sectors like digital health, medical devices, and oral health.
SpringRock Ventures targets early to late-stage companies that show customer acceptance, particularly in healthcare IT and oral health. Their investment range is between $2 million and $5 million, with a specific emphasis on seed and entrepreneur-in-residence stages. The firm is particularly interested in innovations related to software as a service (SaaS), devices, and wellness.
Notable portfolio companies include C-SATS, acquired by Johnson & Johnson; Vascular Solutions, a publicly traded medical device company; Illumina, a leader in genomics; Rosetta Inpharmatics, acquired by Merck & Co.; Aquantive, acquired by Microsoft; and HemoSense, a diagnostic testing device.
Submit your pitch through their form at springrockventures.com or email info@springrockventures.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.